A c c e p t e d m a n u s c r i p t
this approach recently showed evidence of efficacy in a Phase I clinical trial 41 . Other strategies facilitated by this technology include the disruption 42 and excision [43] [44] [45] of proviral DNA from HIVinfected cells, the disruption of endogenous host factors critical for HIV-1 integration 46, 47 , and the attenuation of HIV-1 replication via transcriptional repression 48, 49 . Among the three major DNAtargeting systems, CRISPR/Cas9 can readily be directed to nearly any genomic locus via RNA-DNA complementary base pairing using a chimeric single guide RNA (sgRNA) 50 . Though this system is typically used for inducing DNA cleavage [50] [51] [52] , it can be co-opted for transcriptional modulation by fusing a catalytically inactivated variant of the Cas9 nuclease (referred to as dCas9) 53 with a transcriptional activator [54] [55] [56] or repressor 57 domain. Because the only major restriction for CRISPR/Cas9
B LTR is 634 bp in length and can be subdivided into three regions ( We designed seven sgRNA to overlap with key features of the LTR (Fig. 1a,b) . The U3 region was targeted by sgRNAs 1-5. sgRNAs 4 and 5, in particular, were designed to overlap with the binding sites for NF-κB and Sp-1, respectively, since these transcription factors contribute directly to viral gene expression and latency [65] [66] [67] [68] [69] . The R region, which encodes a repressive mRNA hairpin structure (TAR) that inhibits RNA pol II processivity 70, 71 in the absence of the viral Tat protein, was targeted by sgRNA 6. Finally, the U5 region was targeted by sgRNA 7.
We initially evaluated the ability of two distinct CRISPR complexes to induce gene activation:
(i) dCas9-VP64 54,55 and (ii) the synergistic activation mediator (SAM) complex 61 . dCas9-VP64
comprises dCas9 fused with a tetrameric repeat of the herpes simplex virus VP16 transactivation domain (VP64) 72 (Fig. 1c) . The SAM system similarly contains dCas9-VP64, but also: (a) a modified sgRNA harboring an aptamer that binds to the MS2 bacteriophage coat protein and (b) a tripartite fusion protein
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. Both dCas9 complexes were tested with each of the seven individual sgRNAs, and the level of Cas9-mediated gene activation was directly correlated with EGFP fluorescence. We observed a minimal increase in EGFP expression in cells transfected with dCas9-VP64, with only sgRNA 3 yielding a significant increase (p < 0.05) in the number of EGFP positive cells (Fig. 1d) . Surprisingly, "tiling" the LTR promoter with multiple sgRNAs, which has been shown to lead to increased activation of endogenous genes in HEK293T cells 54, 55 , had minimal effect on EGFP expression in this transient reporter system (Supplementary Fig. 2 ).
In contrast to the dCas9-VP64 complex, HEK293T cells co-transfected with reporter plasmid and the SAM system, showed a 12-to 24-fold increase in the number or percentage of EGFP positive cells, with the most robust levels of activation observed using sgRNAs 1, 2, and 3 (Fig. 1d) . As previously reported 61 , no substantial increase in SAM-mediated activation was observed by tiling the promoter with multiple sgRNAs (Supplementary Fig. 3 ). As a control for target specificity, we evaluated EGFP expression in cells co-transfected with reporter plasmid and SAM encoding a random sgRNA library.
No significant increase in EGFP was observed in transfected cells ( Supplementary Fig. 4 ), indicating that SAM induced specific activation from the HIV-1 LTR promoter.
A c c e p t e d m a n u s c r i p t
Reactivation of latent HIV expression by CRISPR activator complexes
We next evaluated whether SAM could reactivate viral gene expression in established cell line models of HIV-1 latency. Specifically, we sequentially infected the Jurkat-derived lymphocytic cell lines J-Lat 9.2 and J-Lat 10.6 75 with lentiviruses encoding each SAM element (Fig. 2a) . J-Lat cells harbor an integrated but transcriptionally silent HIV-1 provirus that expresses GFP in lieu of the nef and env genes but still recapitulates the natural transcriptional complexity of the HIV promoter, thereby mimicking HIV latency. We specifically chose the J-Lat 9.2 and 10.6 cell lines since they display distinct gene activation thresholds arising from differences in chromatin accessibility at the HIV-1 LTR 76 . Specifically, J-Lat 9.2 is a strongly repressed clone that requires high transcriptional induction to overcome its chromatin environment, whereas J-Lat 10.6 cells possess a lower activation threshold.
We observed GFP expression in ~30% and ~5% of J-Lat 9.2 cells stably expressing SAM with sgRNAs 4 and 6, respectively (Fig. 2b) . Additionally, we observed reactivation in up to 85% of J-Lat 10.6 cells expressing SAM with sgRNA 6 (Fig. 2c) . As an efficient positive induction control, we used tumor necrosis factor alpha (TNF-α), a proinflammatory cytokine that stimulates HIV expression through activation of NF-κB, but whose in vivo toxicity 77 precludes its use as a therapeutic. TNF-α treatment yielded ~18% and ~82% GFP positive J-Lat 9.2 and 10.6 cells, respectively ( Supplementary   Fig. 5 ). Compared to an empty sgRNA cassette, each sgRNA we tested induced an increase (p < 0.05) in the number of GFP positive J-Lat 10.6 cells (Fig. 2c) . However, only two sgRNA (4 and 6) induced a significant increase (p < 0.05 for both) in the number of GFP positive cells in the more repressed J-Lat 9.2 cell line (Fig. 2b) . Taken together, these data indicate that CRISPR/Cas9-based transcription activation systems delivered via lentivirus can stimulate latent HIV gene expression, but that differences in chromatin accessibility at the HIV-1 LTR can affect the ability of Cas9 to stimulate transcription. (Fig. 3b) . Specifically, reactivation was evident in ~70% of J-Lat 9.2 cells with sgRNA 4, and ~80% of J-Lat 10.6 cells with sgRNAs 3, 5, 6, and 7 after treatment with 4 µM SAHA, substantially higher than control cells expressing an empty sgRNA expression cassette (Fig. 3b) . Depending on the sgRNA used, high-doses of SAHA led to a 2-to 5-fold increase in activation in J-Lat 9.2 cells (Fig. 3b) , indicating that CRISPR-based transcriptional modulators and HDAC inhibitors can act synergistically to reactivate HIV-1.
We next investigated whether the use of multiple latency reversing compounds in combination with Cas9 could further increase HIV-1 expression. We treated J-Lat 9.2 and 10.6 cells expressing SAM with escalating doses of SAHA and 2 µM prostratin (Fig. 3a) . The latter small molecule stimulates IKKdependent phosphorylation and degradation of Iκ-Bα 79 , leading to the rapid nuclear translocation of NF-κB and activation of latent provirus 18, 19 . Depending on the sgRNA used, SAM-expressing J-Lat 9.2 cells co-treated with SAHA plus prostratin showed a 2-to 3-fold increase in the number of GFP positive cells compared to those treated with SAHA only (Fig. 3c) . Notably, sgRNAs 4 and 6 stimulated GFP expression in up to 80% of J-Lat 9.2 cells treated with SAHA and prostratin (Fig. 3c) . J-Lat cells A c c e p t e d m a n u s c r i p t expressing SAM and treated with prostratin in the absence of SAHA, however, showed less activation than those treated with both compounds (Supplementary Fig. 6 ).
Interestingly, J-Lat 10.6 cells expressing SAM with sgRNA 4 -whose target site overlaps with the binding sites for NF-κB -showed a marked decrease in GFP positive cells after treatment with prostratin ( Fig. 3c) , indicating the possibility that SAM and NF-κB may be competing for LTR binding sites, and that this interplay led to suboptimal viral gene expression. Collectively, these results indicate that HIV latency reversing compounds can enhance the efficacy of Cas9-mediated activation of HIV-1, particularly in repressive chromatin contexts.
Reactivation of latent HIV by epigenome editing using CRISPR/Cas9-based acetyltransferases
Multiple mechanisms contribute to HIV latency, including repressive local chromatin effects stemming from histone deacetylation of the nucleosomes (nuc-0 and nuc-1) that form within the LTR 80 .
While HDAC inhibitors such as SAHA can stimulate latent HIV expression by promoting an open chromatin environment around the provirus promoter, their activity can also influence the expression of host genes. In contrast, emerging epigenome-modifying technologies 81 have the potential to directly alter the chromatin structure of the LTR and thereby affect target gene expression in a site-specific manner. For instance, fusion of dCas9 with the catalytic histone acetyltransferase core domain of the human E1A-associated protein p300 (dCas9-p300) was recently shown to facilitate transcriptional activation via targeted acetylation of histone H3 in the promoter region of targeted genes (Fig. 4a ) 82 . We thus hypothesized that dCas9-p300 could also reactivate latent HIV-1 expression by acetylation of nuc-0 or nuc-1. To examine this possibility, we evaluated GFP expression in J-Lat 10.6 cells nucleofected with expression vectors encoding dCas9-p300 and the aforementioned LTR-targeted sgRNAs. In particular, sgRNAs 1, 2, and 3 mediate binding near nuc-0, whereas the target sites for sgRNAs 6 and 7 overlap with nuc-1 (Fig. 1a) . dCas9-p300 introduced into cells by nucleofection induced significant gene expression when targeted by sgRNAs 2, 4, 5, and 6 (p < 0.05 for each) (Fig. 4b) , achieving levels of A c c e p t e d m a n u s c r i p t activation comparable to each corresponding SAM complex (which were ~2-fold lower than by lentiviral-mediated expression, see Fig. 2 ). In the case of sgRNA 2, whose target site overlaps with nuc-0, dCas9-p300 induced a significant increase (p < 0.05) in HIV-1 expression over SAM (Fig. 4b) . Likely due to their more repressive transcriptional environment, no significant increase in activation was observed when J-Lat 9.2 cells were nucleofected with dCas9-p300 (data not shown). However, these findings collectively indicate that dCas9-p300 offers strong potential to stimulate transcription from the HIV-1 LTR.
DISCUSSION
The presence of residual latent but replication-competent HIV-1 reservoirs is a major hurdle impeding viral eradication. Recent work has indicated that HIV expression can be induced using zinc- The SAM system used here 61 contains both the activation domain of the HSF1 protein and the NF-κB trans-activating subunit p65, which can stimulate transcriptional elongation during proviral activation 87 . This notwithstanding, we observed no increase in HIV activation in J-Lat cells expressing dCas9-VP64, MS2-p65-HSF1, and an empty sgRNA cassette, indicating that HIV-1 expression was due to sgRNA targeting to the LTR. The modularity of the tripartite MS2-p65-HSF1 fusion protein could be exploited in the future to create a Cas9 activator complex specifically tailored for CD4 + T cells or other cell types relevant to HIV latency.
We also show that epigenome editing using a Cas9 acetyltransferase (dCas9-p300) 82 can lead to a significant increase in GFP expression in J-Lat 10.6 cells. dCas9-p300-induced changes in transcription similar to SAM for multiple sgRNAs including sgRNA 2, which overlaps with a nucleosome (nuc-0) that contributes to proviral silencing. Because SAM and dCas9-p300 function through complementary mechanisms, emerging Cas9 orthologs 88 could be co-opted and used in tandem for multiplexed induction of viral gene expression via epigenome editing and promoter-directed transcriptional activation. Future studies are necessary to determine the effectiveness of these technologies in primary cell models of HIV-1 latency, as well as the DNA-binding specificity of each
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Cas9 activator 89 and the exact epigenetic modifications induced by dCas9-p300. A c c e p t e d m a n u s c r i p t 10% FBS and 1% Anti-Anti in a humidified 5% CO 2 atmosphere at 37°C.
Lentivirus production and infections
HEK293T cells were seeded onto 10-cm plates at a density of 2 x 10 6 cells per plate in serumcontaining medium. At 24 h after seeding, cells were transfected with 10 µg of pLV-dCas9-VP64-Blast, At 48 h after nucleofection, cells were washed once with PBS, and GFP expression was evaluated by flow cytometry. For each sample, 10,000 live events were collected, and data were analyzed using FlowJo.
Statistical analysis
Data represents the mean (data points) and standard deviation (error bars) of three independent replicates. Statistical significance was calculated using a one-tailed independent two-sample Student's t- 
test (Microsoft Excel 2013).
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